<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Human B-lymphocyte-derived lines were forced to enter the EBV-cycle by <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e> with the P3HR-1 substrain of EBV or <z:chebi fb="199" ids="26708">sodium</z:chebi> <z:chebi fb="0" ids="17968">butyrate</z:chebi> treatment </plain></SENT>
<SENT sid="1" pm="."><plain>The induced cells were used as targets for natural killing (NK) and EBV-specific, antibody-dependent cellular cytotoxicity (ADCC) </plain></SENT>
<SENT sid="2" pm="."><plain>Two Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lines, Raji and Daudi, and one <z:mpath ids='MPATH_458'>normal</z:mpath> adult derived lymphoblastoid cell line, <z:chebi fb="0" ids="13389">NAD</z:chebi>-7, were comparable in their ADCC-sensitivity after induction, but only the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived lines showed a major increase in NK-sensitivity </plain></SENT>
<SENT sid="3" pm="."><plain>The <z:e sem="disease" ids="C0038826" disease_type="Disease or Syndrome" abbrv="">superinfection</z:e>-induced membrane change, responsible for both NK and ADCC sensitivity, is an early function of the <z:mp ids='MP_0001799'>viral</z:mp> cycle, correlated with the appearance of early antigens (EA) </plain></SENT>
<SENT sid="4" pm="."><plain>Indirect evidence indicates that the NK and ADCC target sites are different but this problem requires further investigation </plain></SENT>
<SENT sid="5" pm="."><plain><z:chebi fb="199" ids="26708">Sodium</z:chebi> <z:chebi fb="0" ids="17968">butyrate</z:chebi> induced an increased NK sensitivity and EBV-related ADCC sensitivity in the Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-derived P3HR-1 line </plain></SENT>
<SENT sid="6" pm="."><plain>Lymphocyte effectors from different donors showed great differences in their NK and ADCC activity </plain></SENT>
<SENT sid="7" pm="."><plain>Optimal ADCC could be demonstrated with effectors that were intermediate in their NK-activity </plain></SENT>
</text></document>